EIRGENIX, INC. WINS BEST BIOPROCESS EXCELLENCE IN TAIWAN AWARD
2019/02/27 – At this year’s 6th Annual Biologics Manufacturing Asia conference held in Singapore, EirGenix, Inc.’s technological and service achievements within the biopharmaceutical industry were once again recognized on the world stage. EirGenix was awarded the Grand Winner of Best Bioprocess Excellence in Taiwan, triumphing over 8 other Taiwanese companies competing in the same category. This year’s win represents the company’s 3rd consecutive year taking home this prestigious award.
This year’s conference held in Singapore saw over 400 attendees from all across the Asian-Pacific region including Taiwan, Japan, South Korea, China, Malaysia, Indonesia, India, and Australia. Those that came to discuss biopharmaceutical manufacturing at the conference hailed from different backgrounds across the various interested parties, including ones from large multi-national corporations, contract development and manufacturing organizations, academic research institutions, and regulatory agencies. Some of the internationally-renowned companies in attendance included Amgen, Bayer, Charles River, GE Healthcare, Genentech, GSK, Lonza, Merck, Novartis, Pfizer, Roche, Samsung Bioepis.